Planning for Success
Cytel’s Clinical Research Services helps study sponsors plan and implement trials that not only meet the
study objectives, but also improve the sponsor’s overall clinical development strategy.
With unmatched clinical expertise and regulatory experience, drug, biologic and device developers trust
Cytel to determine the best approach to achieve a successful outcome.
Learn More About
Clinical Program Consulting and Trial Design
Clinical Data Processing, Monitoring and Regulatory Submission
Statistical Methods Development Collaborations
Cytel Clinical Services Client Project Profiles
Editor: as we await the proper time to reveal the sponsor, please read this compelling oncology trial work. Accepted by both the FDA and EMEA, it explains the advantages of employing an adaptive sample size re-estimation "Promising Zone" for a cancer treatment confirmatory study.
Read the Adaptive Oncology Trial Project Profile
"When a Patient Population Increase is the Best Bet"
Sample Size Re-Estimation in an Abdominal Cancer Treatment Confirmatory Study
“Cytel’s work on the trial design, simulation and FDA discussions was instrumental in obtaining regulatory acceptance for the proposed methodology in implementing a groundbreaking adaptive trial.”
Read the Population Selection/Enrichment Cardiology Treatment Project Profile
Vice President
Medical Science
Specialty Pharmaceutical Company
“Working together with Cytel allowed our team to move from research to reality with a swiftness not possible without Cytel. We now have the tools to help guide our innovative trial design decision-making efficiently and intelligently.”
Read the Dose-responsive Simulation Software Project Profile
Vice President
Early Stage Biostatistics
Merck Research Labs
“We want to acknowledge Cytel’s pivotal role. Without Cytel we would not have got this far. You have been very service-oriented and responsive.”
Read the Seamless Phase 2 / 3 HIV Related Trial Project Profile
Scott Harris
Chief Medical Officer
Napo Pharmaceuticals